Rebecca W Zeng, Jie Ning Yong, Darren J H Tan, Clarissa E Fu, Wen Hui Lim, Jieling Xiao, Kai En Chan, Caitlyn Tan, Xin Lei Goh, Douglas Chee, Nicholas Syn, Eunice X Tan, Mark D Muthiah, Cheng Han Ng, Nobuharu Tamaki, Sung Won Lee, Beom Kyung Kim, Mindie H Nguyen, Rohit Loomba, Daniel Q Huang
BACKGROUND: Emerging data suggest that statins, aspirin and metformin may protect against hepatocellular carcinoma (HCC) development. However, prior meta-analyses were limited by heterogeneity and inclusion of studies without adequate adjustment for baseline risks. AIM: To examine by an updated meta-analysis the association between these medications and HCC risk. METHODS: Medline and Embase databases were searched from inception to March 2022 for studies that balanced baseline risks between study groups via propensity score matching or inverse probability of treatment weighting, that reported the impact of statins, aspirin or metformin on HCC risk...
March 2023: Alimentary Pharmacology & Therapeutics